sacituzumab
gilead sciences
['breast', 'sacituzumab', 'sacitu, govi', 'tropics-02']
tropics-02 trial: os data further support sacituzumab govitecan in hr+/her2 metastatic #breastcancer #esmo22 
The European Society for Medical Oncology (ESMO) is the leading organisation for cancer education and information, supporting the oncology community’s work.